Tranexamic Acid (Amring Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Tranexamic Acid drug offered from Amring Pharmaceuticals, Inc.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amring Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Tranexamic Acid |
| SUBSTANCE NAME: | TRANEXAMIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Tranexamic Acid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tranexamic Acid from Amring Pharmaceuticals, Inc. |
| LABELER NAME: | Amring Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 650(mg/1) |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69918-301_c520a9a4-7764-40b7-b261-9070216870c1 |
| PRODUCT NDC: | 69918-301 |
| APPLICATION NUMBER: | NDA022430 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers:
